Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2008; 14(20): 3165-3173
Published online May 28, 2008. doi: 10.3748/wjg.14.3165
Table 2 Percentage distribution (weighted for the sampling fraction) of treatment characteristics and survival for gastroesophageal adenocarcinoma patients diagnosed in 2001 NCI: Patterns of care study (n = 1356)1 (Wt%)
Lower esophagus
Gastric cardia
Stomach
I-IIIIV-VI-IIIIV-VI-IIIIV-V
Therapy received
Surgery only12.31.3342.249.615.7
Radiation only8.13.54.77.223.3
Chemotherapy only0.5241.221.93.622.1
Surgery and radiation0.802.60.93.90.4
Surgery and chemo2.51.38.64.83.25.6
Surgery, rad, chemo274.62511.219.26.1
Chemo and radiation36.546.89.812.41.53.4
None12.418.714.139.417.143.4
Chemotherapy
No chemo25.121.548.740.864.954.5
Single agent5.425.511.49.910.38.4
Multi-agent61.150.931.439.617.129
Refused5.91.54.37.244.3
Rec, unknown if given1.9012.11.82.3
Unknown0.60.63.20.421.5
Chemotherapy agent
5-FU58.637.935.734.723.226.4
Doxorubicin0.500.310.53.4
Capecitabine1.200.77.40.64
Cisplatin38.737.22217.22.810.8
Etoposid100.710.71.45.8
Irinotecan0.712.90.55.91.65.6
Leucovorin4.10.96.121.812.115.1
Mitomycin-C13.4.30.50.60.21.8
OxaliplatinNo one
Epirubicin000101.2
Paclitaxel11.820.85.97.32.24.6
Docetaxel01.60.72.10.61.4
Chemotherapy plus surgery (with or without radiation)
No70.594.268.38477.787.8
Pre-op23.74.916.86.40.30.5
Post-op5.80.998.520.311.2
Unknown005.91.11.70
Surgery plus chemotherapy and radiation
No7395.47588.580.993.9
Pre-op21.94.613.44.30.20.5
Post-op5.108.66.917.45.6
Unknown00301.50
Median survival time (mo)
Non-surgical pts1388654
Surgical patients22131913266